FDA 510(k) Clearances - April 2021

255 medical devices cleared by the FDA. Data sourced from the FDA 510(k) public files.

255
Cleared
15
Specialties
149d
Avg review

April 2021 overview

The FDA cleared 255 medical devices in April 2021 through the 510(k) premarket notification pathway. This compares to 272 clearances in March 2021 - a decrease of 17 (-6.2%).

Orthopedic led all specialties with 51 cleared devices. The fastest average review was Ophthalmic at 106 days. The slowest was Physical Medicine at 351 days.

Overall average review time: 149 days, ranging from 2 to 677 days. The FDA's standard 510(k) review target is 90 days.

Clearances by specialty - April 2021

Detailed data

Review time in calendar days from FDA receipt to decision. Source: FDA 510(k) downloadable files.

Specialty Cleared Avg days Min Max vs March
Orthopedic 51 126 17 435 +8
Radiology 38 121 14 437 +1
General Hospital 35 176 30 407 -33
General & Plastic Surgery 28 160 27 539 +9
Cardiovascular 26 123 25 242 +3
Gastroenterology & Urology 18 121 15 448 +10
Dental 17 161 2 437 -3
Neurology 11 234 21 677 -7
Ophthalmic 9 106 29 244 +6
Anesthesiology 7 185 113 287 -3
Obstetrics & Gynecology 7 171 89 275 +5
Physical Medicine 5 351 209 619 -6
Pathology 1 150 150 150 +1
Chemistry 1 256 256 256 +1
Toxicology 1 144 144 144 -
Total 255 149 2 677 -17

Key observations

Fastest reviews

The fastest individual clearance took 2 days. Reviews under 5 days typically reflect Special 510(k) submissions for minor modifications to already-cleared devices.

Longest review

The longest individual review reached 677 days. Extended reviews typically indicate additional information requests or complex predicate device questions. The FDA's standard target is 90 days from receipt.

Leading specialty: Orthopedic

Orthopedic led April 2021 with 51 clearances - 20% of all monthly clearances.

Review time spread

Physical Medicine posted the highest average at 351 days. Ophthalmic was fastest at 106 days. The gap of 245 days between fastest and slowest specialties reflects differences in device complexity and regulatory pathway.

Most active manufacturers

The most active manufacturers in April 2021 were Medacta International S.A. (5) , Boston Scientific Corporation (3) , Canon Medical Systems Corporation (3) , Medline Industries, Inc. (2) and Wide Corporation (2) . Together, these five manufacturers accounted for 15 of the 255 total clearances - 6% of all April activity.

About this data

This report covers FDA 510(k) submissions with a decision date in April 2021 and a valid days-to-decision value. Data is sourced from the FDA 510(k) public files, published on the 5th of each month and in the public domain (17 U.S.C. § 105). Only cleared decisions are counted (SESE, SESK, SESU, SEKD, SESP, SESD, ST, SN).

Maintained by Space Bits, S.L. Not affiliated with or endorsed by the FDA. Verify at accessdata.fda.gov.